In vitro and in vivo immunosuppresive characteristics of hepatocyte growth factor-modified murine mesenchymal stem cells

In Vivo

Volumn 23, Issue 1, 2009, Pages 21-28

  Bian, Li ^a   Guo, Zi Kuan ^b   Wang, Heng Xiang ^c   Wang, Jin Song ^b   Wang, Hua ^b   Li, Qing Fang ^b   Yang, Yue Feng ^b   Xiao, Feng Jun ^b   Wu, Cu Tse ^b   Wang, Li Sheng ^b  

^a Beijing 307 Hospital   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c AIR FORCE GENERAL HOSPITAL   (China)

Author keywords

Hepatocyte growth factor; Immune modulation; Mesechymal stem cells

Indexed keywords

ADENOVIRUS VECTOR; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD11B ANTIGEN; COMPLEMENTARY DNA; CONCANAVALIN A; ENHANCED GREEN FLUORESCENT PROTEIN; SCATTER FACTOR; CD11 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; MITOGENIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL EXPANSION; CELL ISOLATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; SKIN GRAFT; STEM CELL GENE THERAPY; SURVIVAL TIME; VIRAL GENE DELIVERY SYSTEM; ALLOTRANSPLANTATION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; GENE THERAPY; GENETICS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; SKIN TRANSPLANTATION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD11; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; GENE THERAPY; GRAFT SURVIVAL; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MITOGENS; SKIN TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 63049103761     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Doulglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and Marshak DR: Multilineage potential of adult mesenchymal stem cells. Science 284: 143-147, 1999.
2. Muraglia A, Cancedda R and Quarto R: Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113: 1161-1166, 2000.
3. Aggarwal S and Pittenger MF: Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105: 1815-1822, 2005.
4. Rasmusson I: Immune modulation by mesenchymal stem cells. Exp Cell Res 312: 2169-2179, 2006.
5. Zhao RC, Liao L and Han Q: Mechanisms of and perspectives on the mesenchymal stem cell in immunotherapy. J Lab Clin Med 143: 284-291, 2004.
6. Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E, Giunti D, Ceravolo A, Cazzanti F, Frassoni F, Mancardi G and Ucceli A: Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106: 1755-1761, 2005.
7. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M and Ringdén O: Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363: 1439-1441, 2004.
8. Chen S, Fang W, Qian J, Ye F, Liu Y, Shan S, Zhang JJ, Lin S, Liao LM and Zhao RC: Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. Chin Med J 117: 1443-1448, 2004.
9. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS and Dzau VJ: Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9: 1195-1201, 2003.
10. Sundres M, Norol F, Trenado A, Gregoire S, Charlotte F, Levacher B, Lataillade JJ, Bourin P, Holy X, Vernant JP, Klatzmann D and Cohen JL: Bone marrow stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice. J Immunol 176: 7761-7767, 2006.
11. Duan HF, Wu CT, Wu DL, Lu Y, Liu HJ, Ha XQ, Zhang QW, WANG H, Jia XX and Wang LS: Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor. Mol Ther 8: 467-474, 2003.
12. Liu HJ, Duan HF, Lu ZZ, Wang H, Zhang QW, Wu ZZ and Wang LS: Influence of hepatocyte growth factor on biological characteristics of bone marrow-derived mesenchymal stem cells. Chin J Exp Hematol 13: 1044-1048, 2005 (in Chinese).
13. Okunishi K, Dohi M, Nakagome K, Tanaka R, Mizuno S, Matsumoto K, Miyazaki J, Nakamura T and Yamamoto K: A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J Immunol 175: 4745-4753, 2005.
14. Imado T, Iwasaki T, Kataoka Y, Kuroiwa T, Hara H, Fujimoto J and Sano H: Hepatocyte growth factor preserves graft-versus-leukemia effect and T-cell reconstitution after marrow transplantation. Blood 104: 1542-1549, 2004.
15. Guo Z, Li H, Li X, Yu X, Wang H, Tang P and Mao N: In vitro characteristics and in vivo immunosuppressive activity of compact bone-derived mesenchymal progenitor cells. Stem Cells 24: 922-1000, 2006.
16. Quo Z, Yang J, Liu X, Li X, Hou C, Tang PH and Mao N: Biological features of mesenchymal stem cells from human bone marrow. Chin Med J 114: 950-953, 2001.
17. Zhang L and Miller RG: The correlation of prolonged survival of maternal skin grafts with the presence of naturally transferred maternal T-cells. Transplantation 56: 918-921, 1993.
18. Godfrey WR, Krampf MR, Taylor PA, and Blazer BR: Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation. Blood 103: 1158-1165, 2004.
19. Beyth S, Borovsky Z, Mevorach D, Liebergall M, Gazit Z, Aslan H, Galun E and Rachmilewitz J: Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105: 22214-22219, 2005.
20. Gur-Wahnon D, Borovsky Z, Beyth S, Liebergall M, Rachmilewitz J: Contact-dependent induction of regulatory antigen-presenting cells by human mesenchymal stem cells is mediated via STAT3 signaling. Exp Hematol 35: 426-33, 2007.
21. Mirotsou M, Zhang Z, Deb A, Zhang L, Gnecchi M, Noiseux N, Mu H, Pachori A and Dzau V: Secreted frizzled-related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci USA 104: 1643-1648, 2007.
22. Benoit DS, Tripodi MC, Blanchette JO, Langer SJ, Leinwand LA and Anseth KS: Integrin-linked kinase production prevents anoikis in human mesenchymal stem cells. J Biomed Mater Res 81A: 259-268, 2007.
23. Jiang S, Haider HKh, Idris NM, Salim A and Ashraf M: Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair: Circ Res 99: 776-784, 2006.
24. Li Y, Yu X, Lin S, Li X, Zhang S and Song YH: Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cells. Biochem Biophys Res Commun 356: 780-784, 2007.
25. Wilson EM and Rotwein P: Control of MyoD function during initiation of muscle differentiation by an autocrine signaling pathway activated by insulin-like growth factor-II. J Biol Chem 281: 29962-29971, 2006.
26. Kuroiwa T, Kakishita E, Hamano T, Kataoka Y, Seto Y, Iwata N, Kaneda Y, Matsumoto K, Nakamura T, Ueki T, Fujimoto J and Iwasaki T: Hepatocyte growth factor ameliorates acute graft-versus-host disease and promotes hematopoietic function. J Clin Invest 107: 1365-1373, 2001.